EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische StudieValidierungsstudieOpen Access · CC BY-NC-ND 4.0

Validation and proposal of a clinical intervention cutoff in fetal scalp blood for the point‐of care‐lactate meter StatStrip ® 2

Sofie Gellert, Sara Norrestam, Alexandra Tidstedt, Claes Ignell, Per-Erik Isberg, Nana Wiberg iD, Linda Iorizzo iD

Acta Obstetricia et Gynecologica Scandinavica · 2025

DOI: 10.1111/aogs.70080 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Acta Obstetricia et Gynecologica Scandinavica, 2025. Verfasst von Sofie Gellert und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Zealand University Hospital, Roskilde, Denmark. Hauptthemen laut MEDLINE: Fetal Blood, Scalp, Lactic Acid, Point-of-Care Systems. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: LÖF The Swedish patient insurance, USVE Skåne University Hospital, Region Skåne, Helsingborg hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

This multicenter, prospective observational study aimed to evaluate the performance of the StatStrip ® Lactate 2 (Nova Biomedical, Waltham, US) point‐of‐care device for fetal blood lactate measurement and to determine the corresponding lactate value equivalent to the established intervention cutoff used with the outgoing StatStrip ® Lactate device. Material and Methods The study was conducted from August 2024 to February 2025 at two maternity clinics in Sweden and one in Denmark. It included women with singleton pregnancies (≥35 + 0 weeks) undergoing fetal blood sampling due to non‐reassuring intrapartal fetal heart rate patterns during labor. Fetal scalp blood sampling (FBS) lactate concentrations were measured using both StatStrip ® Lactate and StatStrip ® Lactate2. The first StatStrip ® Lactate measurement guided clinical decisions, while subsequent StatStrip ® Lactate2 measurements were recorded for validation and establishment of a conversion equation by linear regression. Additionally, arterial and venous umbilical cord blood samples were analyzed by both ABL 800 (Radiometer, Denmark) and StatStrip ® Lactate2 for validation.

Results

Blood samples from 349 fetuses were included, with 549 parallel FBS lactate samples. StatStrip ® Lactate2 concentrations correlated with StatStrip ® Lactate ( r = 0.94; p ≤ 0.001). A conversion equation was retrieved: StatStrip ® Lactate2 = (1.4 × StatStrip ® Lactate) − 0.28. From 37 paired umbilical cord blood samples, the correlation between lactate concentrations by StatStrip ® Lactate2 and ABL800 was r = 0.99 ( p ≤ 0.001) in arterial blood and r = 0.98 ( p ≤ 0.001) in venous blood. Mean coefficients of variation for lactate concentrations >3.0 mmol/L were 8.2% in fetal scalp blood and 3.8% in umbilical cord blood.

Conclusions

A fetal blood lactate concentration ≥7.0 mmol/L measured by StatStrip ® Lactate2 corresponds to the established intervention cutoff lactate value ≥5.2 mmol/L measured by StatStrip ® Lactate. Precision was acceptable but may be improved by using the mean of two measurements, particularly when the first result falls between 6.0 and 8.0 mmol/L. We also recommend ensuring the correct sampling techniques to minimize preanalytical variation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fetal BloodScalpLactic AcidPoint-of-Care SystemsFetal MonitoringHumansFemalePregnancyProspective StudiesAdultDenmarkSweden

Stichwörter der Autor:innen

acidosisfetal bloodfetal monitoringlactic acidpoint‐of‐care testing

Substanzen

Lactic Acid

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Zealand University Hospital, Roskilde, Denmark.
  • Department of Obstetrics and Gynecology, Helsingborg Hospital, Helsingborg, Sweden.
  • Department of Obstetrics and Gynecology, Höglandssjukhuset, Eksjö, Sweden.
  • Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Department of Statistics, Lund University, Lund, Sweden.
  • Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.

ORCID-Profile: Nana Wiberg, Linda Iorizzo

Förderung

  • LÖF The Swedish patient insurance
  • USVE Skåne University Hospital
  • Region Skåne, Helsingborg hospital
  • Region Skåne

Zitieren

APA

Gellert, S., Norrestam, S., Tidstedt, A., Ignell, C., Isberg, P. E., Wiberg, N., & Iorizzo, L. (2025). Validation and proposal of a clinical intervention cutoff in fetal scalp blood for the point‐of care‐lactate meter StatStrip ® 2. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/aogs.70080

Vancouver

Gellert S, Norrestam S, Tidstedt A, Ignell C, Isberg PE, Wiberg N, et al. Validation and proposal of a clinical intervention cutoff in fetal scalp blood for the point‐of care‐lactate meter StatStrip ® 2. Acta Obstetricia et Gynecologica Scandinavica. 2025. doi:10.1111/aogs.70080

BibTeX
@article{Gellert2025,
  author = {Gellert, Sofie and Norrestam, Sara and Tidstedt, Alexandra and Ignell, Claes and Isberg, Per-Erik and Wiberg, Nana and Iorizzo, Linda},
  title = {Validation and proposal of a clinical intervention cutoff in fetal scalp blood for the point‐of care‐lactate meter StatStrip ® 2},
  journal = {Acta Obstetricia et Gynecologica Scandinavica},
  year = {2025},
  doi = {10.1111/aogs.70080}
}
Kostenlos starten →